VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
XYL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
XYLXylem Inc.
$101.84$23.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXYLBalance Sheet

Xylem Inc. (XYL) Balance Sheet

17Y historyFree accessUpdated daily

Debt-to-equity rose to 0.29 in 2026Q2 from 0.18 in 2026Q1, with total debt increasing by $1.0B sequentially, while goodwill of $8.3B represents 48% of total assets, suggesting acquisition-driven growth and potential impairment risk.

Income StatementBalance SheetCash FlowRatios

XYL Balance Sheet

Annual statement

XYL Balance Sheet

Xylem Inc. (XYL) balance sheet — 17-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Total Current Assets4.39B4.64B4.09B3.88B3.01B3.16B3.52B2.45B2.09B2.07B1.84B2B2.06B2.01B1.87B1.64B1.34B1.09B
Cash & Short-Term Investments1.28B1.48B1.12B1.02B944M1.35B1.88B724M296M414M308M680M663M533M504M318M131M81M
Cash Only1.28B1.48B1.12B1.02B944M1.35B1.88B724M296M414M308M680M663M533M504M318M131M81M
Short-Term Investments000000000000000000
Accounts Receivable1.88B1.76B1.67B1.62B1.1B953M923M1.04B1.03B956M843M749M771M817M776M756M690M599M
Days Sales Outstanding72.3271.0671.1180.1572.4466.9669.0972.0472.2774.1381.674.8471.8677.7274.7172.5678.6576.74
Inventory1.02B983M996M1.02B799M700M558M539M595M524M522M433M486M475M443M426M389M301M
Days Inventory Outstanding66.2464.5367.9579.9684.8379.3566.8661.4268.2766.9782.4870.2773.8274.1670.6466.3971.4260.63
Other Current Assets8M176M309M230M173M0000000041M41M45M47M54M
Total Non-Current Assets12.95B12.99B12.39B12.23B4.94B5.12B5.23B5.26B5.13B4.79B4.63B2.65B2.77B2.89B2.81B2.75B2.4B1.45B
Property, Plant & Equipment1.17B1.55B1.15B1.17B630M644M657M658M656M643M616M439M461M488M487M463M454M334M
Fixed Asset Turnover7.29x5.83x7.43x6.30x8.77x8.07x7.42x7.98x7.94x7.32x6.12x8.32x8.49x7.86x7.78x8.21x7.05x8.53x
Goodwill8.26B8.33B7.98B7.59B2.72B2.79B2.85B2.84B2.98B2.77B2.63B1.58B1.64B1.72B1.65B1.61B1.44B970M
Intangible Assets2.15B2.27B2.38B2.53B930M1.02B1.09B1.17B1.23B1.17B1.2B435M431M488M484M505M416M91M
Long-Term Investments8M050M9M79M8M04M0000000000
Other Non-Current Assets1.37B698M834M934M582M656M623M585M264M210M186M194M203M193M187M173M92M52M
Total Assets17.34B17.63B16.49B16.11B7.95B8.28B8.75B7.71B7.22B6.86B6.47B4.66B4.83B4.9B4.68B4.39B3.73B2.54B
Asset Turnover0.53x0.51x0.52x0.46x0.69x0.63x0.56x0.68x0.72x0.69x0.58x0.78x0.81x0.78x0.81x0.87x0.86x1.12x
Asset Growth %17.97%6.92%2.36%102.62%-3.91%-5.42%13.49%6.76%5.28%5.96%39.02%-3.64%-1.29%4.64%6.51%17.62%47.34%-
Total Current Liabilities2.72B2.86B2.34B2.21B1.59B1.39B1.96B1.5B1.39B1.1B1.24B823M903M853M781M817M649M571M
Accounts Payable1.01B1.01B1.01B968M723M639M569M597M586M549M457M338M338M332M332M322M297M238M
Days Payables Outstanding65.2266.568.6376.0376.7672.4368.1868.0367.2470.1672.2154.8651.3451.8352.9450.1854.5347.94
Short-Term Debt531M534M38M16M69M69M663M337M257M0260M78M89M42M6M5M00
Deferred Revenue (Current)000000000000000000
Other Current Liabilities309M443M430M403M285M273M258M156M194M203M182M156M186M144M201M219M224M162M
Current Ratio1.61x1.63x1.75x1.76x1.89x2.27x1.80x1.63x1.51x1.88x1.49x2.44x2.29x2.36x2.40x2.01x2.06x1.91x
Quick Ratio1.24x1.28x1.33x1.30x1.39x1.77x1.52x1.27x1.08x1.41x1.06x1.91x1.75x1.80x1.83x1.49x1.46x1.38x
Cash Conversion Cycle73.3469.0970.4284.0780.5173.8767.7765.4373.370.9491.8790.2694.34100.0492.4188.7795.5589.43
Total Non-Current Liabilities3.95B3.03B3.27B3.73B2.86B3.66B3.82B3.24B3.05B3.24B3.03B1.75B1.83B1.8B1.82B1.75B367M277M
Long-Term Debt2.4B1.41B1.98B2.27B1.88B2.44B2.48B2.04B2.05B2.2B2.11B1.2B1.2B1.2B1.2B1.2B4M0
Capital Lease Obligations000000000000000000
Deferred Tax Liabilities1.78B405M497M557M222M287M242M310M303M252M352M118M158M191M173M165M99M60M
Other Non-Current Liabilities1.11B1.22B800M906M757M932M1.09B892M697M789M569M436M472M412M452M383M264M217M
Total Liabilities6.92B5.88B5.62B5.94B4.45B5.05B5.77B4.74B4.44B4.34B4.27B2.57B2.74B2.65B2.6B2.57B1.02B848M
Total Debt3.06B2.06B2.13B2.39B1.95B2.51B3.15B2.38B2.31B2.2B2.37B1.27B1.28B1.24B1.21B1.21B4M0
Net Debt1.78B584M1B1.37B1B1.16B1.27B1.65B2.01B1.79B2.06B594M621M708M701M888M-127M-81M
Debt / Equity0.29x0.18x0.20x0.23x0.56x0.78x1.06x0.80x0.83x0.87x1.07x0.61x0.60x0.55x0.58x0.66x0.00x-
Debt / EBITDA1.62x1.15x1.35x2.20x2.27x3.02x5.09x3.20x2.52x2.80x4.25x2.19x2.12x2.42x1.92x2.27x0.01x-
Net Debt / EBITDA0.94x0.32x0.64x1.26x1.17x1.40x2.06x2.22x2.20x2.27x3.70x1.02x1.03x1.38x1.12x1.67x-0.26x-0.23x
Interest Coverage56.35x41.72x25.70x13.96x9.80x7.72x4.70x7.21x8.38x7.07x6.94x8.27x9.06x8.24x8.05x23.53x--
Total Equity10.42B11.75B10.88B10.18B3.5B3.23B2.98B2.97B2.78B2.52B2.21B2.08B2.13B2.24B2.07B1.83B2.72B1.69B
Equity Growth %9.7%7.97%6.94%190.49%8.59%8.4%0.3%6.65%10.44%14.14%5.9%-2.02%-5.09%8.05%13.52%-32.81%61.17%-
Book Value per Share44.0648.1544.6946.6419.3617.7716.4316.3715.3613.9212.2611.4711.5512.0511.149.8614.739.14
Total Shareholders' Equity10.42B11.48B10.64B10.17B3.49B3.22B2.97B2.96B2.77B2.5B2.19B2.08B2.13B2.24B2.07B1.83B2.72B1.69B
Common Stock3M3M3M3M2M2M2M2M2M2M2M2M2M2M2M2M2.36B1.27B
Retained Earnings3.96B3.71B3.14B2.6B2.29B2.15B1.93B1.87B1.64B1.23B1.03B885M648M405M264M40M00
Treasury Stock-2.02B-768M-753M-733M-708M-656M-588M-527M-487M-428M-403M-399M-220M-86M-13M000
Accumulated OCI-302M-220M-435M-269M-226M-371M-413M-375M-336M-210M-318M-238M-99M167M115M122M358M415M
Minority Interest3M269M240M10M9M8M8M10M14M16M17M0000000

Key Metrics

Growth RegimeStable
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Integration and international softness

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Expansion with Rising Leverage

Total assets grew to $17.3B in 2026Q2 from $15.9B in 2024Q1, per reported figures, while debt-to-equity rose to 0.29 from 0.23, indicating a shift toward leverage.

The balance sheet has expanded steadily, driven largely by retained earnings growth from $2.7B to $4.0B over the period. However, the recent jump in total debt to $3.1B in 2026Q2 from $2.1B in the prior quarter suggests a strategic increase in leverage, possibly to fund capital returns or acquisitions. This trend warrants monitoring as it may signal a departure from the historically conservative capital structure.

Leverage Inflection Points to Strategic Shift

Debt-to-equity rose to 0.29 in 2026Q2 from 0.18 in 2026Q1, as reported in financial statements, while total debt increased by $1.0B sequentially, suggesting a deliberate leverage increase.

The sharp increase in debt in 2026Q2 appears to be a strategic move, possibly to finance share repurchases or acquisitions, given the concurrent rise in retained earnings. Despite the increase, leverage remains moderate compared to peers like Pentair (D/E 0.46), indicating ample headroom. Investors should monitor whether this leverage is a one-time event or a new trend, as it could impact future cash flow durability.

Asset Mix Reflects Acquisition-Driven Growth

Goodwill rose to $8.3B in 2026Q2 from $7.5B in 2024Q1, per SEC filings, now representing 48% of total assets, while PPE remained stable at $1.2B, indicating an asset-light model.

The significant goodwill balance, largely from the Evoqua and Sensus acquisitions, underscores the company's strategy of growth through M&A rather than organic capital expenditure. The stable PPE suggests a mature asset base with maintenance-focused spending. However, the high goodwill concentration poses an impairment risk if integration fails to deliver expected synergies, which could pressure future earnings.

Retained Earnings Drive Equity Quality

Equity grew to $10.4B in 2026Q2 from $10.2B in 2024Q1, as reported, with retained earnings increasing by $1.3B, indicating strong internal capital generation.

The growth in equity is primarily attributable to retained earnings, which rose from $2.7B to $4.0B over the period, reflecting consistent profitability. The absence of significant stock-based compensation, as noted in prior analysis, suggests reported earnings are not diluted by non-cash charges. This high-quality equity base supports the company's ability to fund future investments and return capital to shareholders.

Liquidity Buffer Remains Adequate

Current ratio improved to 1.61 in 2026Q2 from 1.46 in 2026Q1, per reported figures, while cash rose to $1.3B, providing a cushion against short-term obligations.

The current ratio, though slightly below the 2025Q3 peak of 1.96, remains above 1.5, indicating sufficient short-term liquidity. Cash increased to $1.3B, up from $808M in the prior quarter, likely due to debt issuance. This buffer appears adequate to cover operational needs and potential working capital swings, though the reliance on debt for liquidity is a point to monitor.

Goodwill Concentration Masks Asset Quality

Goodwill of $8.3B represents 48% of total assets as of 2026Q2, per financial statements, a level that could distort return-on-asset metrics and signal impairment risk.

The substantial goodwill balance, a result of aggressive acquisition strategy, may overstate the company's asset base and understate its true economic returns. If the anticipated synergies from Evoqua fail to materialize, an impairment charge could significantly reduce equity and earnings. Investors should scrutinize the performance of acquired segments, particularly MCS, to assess the sustainability of the current asset valuation.

XYL — Frequently Asked Questions

Quick answers to the most common questions about buying XYL stock.

What are the total assets of Xylem Inc. (XYL)?

As of 2025, Xylem Inc. (XYL) had total assets of $17.63B including $4.64B in current assets.

How much debt does Xylem Inc. (XYL) have?

Xylem Inc. (XYL) carries total debt of $2.06B, offset by $1.48B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Xylem Inc.?

Xylem Inc. (XYL) has total shareholders' equity (book value) of $11.48B ($48.15 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Xylem Inc.'s current ratio and liquidity?

Xylem Inc. (XYL) reported a current ratio of 1.63x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.